|
MFN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.393400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.164700E-04 |
| Normal-vs-Stage2 |
2.796600E-01 |
| Normal-vs-Stage3 |
3.27229999996792E-06 |
| Normal-vs-Stage4 |
5.805500E-04 |
| Stage1-vs-Stage2 |
8.111700E-02 |
| Stage1-vs-Stage3 |
8.953900E-02 |
| Stage1-vs-Stage4 |
4.003800E-01 |
| Stage2-vs-Stage3 |
1.227590E-02 |
| Stage2-vs-Stage4 |
5.073700E-02 |
| Stage3-vs-Stage4 |
6.774000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.96801999999829E-05 |
| Normal-vs-AfricanAmerican |
2.801400E-01 |
| Normal-vs-Asian |
1.142070E-02 |
| Caucasian-vs-AfricanAmerican |
6.424000E-02 |
| Caucasian-vs-Asian |
4.462600E-01 |
| AfricanAmerican-vs-Asian |
3.035000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.246730E-04 |
| Normal-vs-Female |
6.990900E-04 |
| Male-vs-Female |
3.649200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.497600E-03 |
| Normal-vs-Age(41-60Yrs) |
5.65550000000137E-05 |
| Normal-vs-Age(61-80Yrs) |
7.240700E-03 |
| Normal-vs-Age(81-100Yrs) |
3.651800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.304000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.577400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.848200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.884200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.956600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.701600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.335700E-03 |
| Classical-VS-Follicular |
7.091600E-02 |
| Classical-VS-Other |
2.661400E-01 |
| Classical-VS-Normal |
2.559000E-04 |
| Tall-VS-Follicular |
6.569100E-04 |
| Tall-VS-Other |
9.254400E-01 |
| Tall-VS-Normal |
9.71259999982266E-07 |
| Follicular-VS-Other |
1.480620E-01 |
| Follicular-VS-Normal |
1.249590E-01 |
| Other-VS-Normal |
1.014170E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.317000E-03 |
| Normal-vs-N1 |
4.87329999998565E-06 |
| N0-vs-N1 |
1.448220E-02 |
|
|
